The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 study of novel MDM2 inhibitor alrizomadlin (APG-115) with or without toripalimab in patients (pts) with advanced adenoid cystic carcinoma (ACC) or other solid tumors.
 
Ye Guo
Honoraria - BeiGene; Merck Serono; MSD; Roche
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; MSD
 
Ning Li
No Relationships to Disclose
 
Xing Zhang
No Relationships to Disclose
 
Meiyu Fang
No Relationships to Disclose
 
Shuhang Wang
No Relationships to Disclose
 
Yan Yu
Employment - Ascentage Pharma
Stock and Other Ownership Interests - Ascentage Pharma
 
Lichuang Men
Employment - Ascentage Pharma
Stock and Other Ownership Interests - Ascentage Pharma
 
Hengbang Wang
Employment - Ascentage Pharma
Stock and Other Ownership Interests - Ascentage Pharma
 
Yifan Zhai
Employment - Ascentage Pharma; Ascentage Pharma; Ascentage Pharma (I); Ascentage Pharma (I)
Leadership - Ascentage Pharma; Ascentage Pharma; Ascentage Pharma (I); Ascentage Pharma (I)
Stock and Other Ownership Interests - Ascentage Pharma; Ascentage Pharma (I)